Race and Modifiable Factors Influencing Cardiovascular Disease

被引：3
|
作者：
Headen, Alvis Coleman [1 ,4 ]
Siaw-Asamoah, Andrew [1 ,4 ]
Julien, Howard M. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Penn Cardiovasc Outcomes Qual & Evaluat Res Ctr, Philadelphia, PA 19104 USA
[3] Penn Cardiovasc Ctr Hlth Equ & Social Justice, Philadelphia, PA 19104 USA
[4] Perelman Ctr Adv Med, 3400 Civ Ctr Blvd,2nd Floor East, Philadelphia, PA 19104 USA
来源：
MEDICAL CLINICS OF NORTH AMERICA | 2022年 / 106卷 / 02期
关键词：
Hypertension; Hyperlipidemia; Race; Health care disparities; AFRICAN-AMERICANS; HYPERTENSION; RACISM; PREVALENCE; BLACKS; PEOPLE;
D O I：
10.1016/j.mcna.2021.11.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A modern approach to mitigating the impact of cardiovascular disease on Americans demands not only an understanding of modifiable conditions that contribute to its development but also a greater appreciation of the heterogeneous distribution of these conditions based on race. As race is not a biological construct, further research is needed to fully elucidate the mechanisms that contribute to these differences. The consequences of the differential impact of modifiable risk factors on cardiovascular disease outcomes among black Americans compared with white Americans cannot be understated.
引用
收藏
页码：401 / +
页数：10
相关论文
共 50 条
  • [31] Study on the changes of cardiovascular disease influencing factors of pilots in China
    Tang, Lihua
    Bian, Chen
    Fang, Lin
    Xiong, Ying
    PROCEEDINGS OF 2020 IEEE 2ND INTERNATIONAL CONFERENCE ON CIVIL AVIATION SAFETY AND INFORMATION TECHNOLOGY (ICCASIT), 2020, : 57 - 60
  • [32] Trends in prescribing rate of statins at discharge and modifiable factors in patients with atherosclerotic cardiovascular disease
    Huang, Bao-tao
    Peng, Yong
    Huang, Fang-yang
    Xia, Tian-li
    Gui, Yi-yue
    Liao, Yan-biao
    Pu, Xiao-bo
    Chen, Shi-jian
    Yang, Yong
    Chen, Mao
    INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (08) : 1121 - 1129
  • [33] Trends in prescribing rate of statins at discharge and modifiable factors in patients with atherosclerotic cardiovascular disease
    Bao-tao Huang
    Yong Peng
    Fang-yang Huang
    Tian-li Xia
    Yi-yue Gui
    Yan-biao Liao
    Xiao-bo Pu
    Shi-jian Chen
    Yong Yang
    Mao Chen
    Internal and Emergency Medicine, 2017, 12 : 1121 - 1129
  • [34] Cardiovascular disease in type 2 diabetes Attributable risk due to modifiable risk factors
    Zeber, John
    Parchman, Michael L.
    CANADIAN FAMILY PHYSICIAN, 2010, 56 (08) : E302 - E307
  • [35] Age-Dependent Association Between Modifiable Risk Factors and Incident Cardiovascular Disease
    Kaneko, Hidehiro
    Yano, Yuichiro
    Okada, Akira
    Itoh, Hidetaka
    Suzuki, Yuta
    Yokota, Isao
    Morita, Kojiro
    Fujiu, Katsuhito
    Michihata, Nobuaki
    Jo, Taisuke
    Yamaguchi, Satoko
    Takeda, Norifumi
    Morita, Hiroyuki
    Node, Koichi
    Yamauchi, Toshimasa
    Nangaku, Masaomi
    Kadowaki, Takashi
    McEvoy, John W.
    Lam, Carolyn S. P.
    Yasunaga, Hideo
    Komuro, Issei
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (02):
  • [36] Modifiable risk factors for cardiovascular disease in Iraqi Kurdistan population: a large epidemiological study
    Murad, Nawzad Sulaiman
    Miro, Shawkat Salih
    Ismael, Vazheen Abdul Hameed
    Abdulah, Deldar Morad
    HEALTHCARE IN LOW-RESOURCE SETTINGS, 2024, 12 (02)
  • [37] Modifiable cardiovascular risk factors in patients with Behçet’s disease: a multicenter experience
    Emad El-Shebiny
    Amira El-Fakharany
    Enas Zahran
    Sabry Shoeib
    Mohamed Salem
    Mohammed Elnaggar
    Nibal Morad
    The Egyptian Journal of Internal Medicine, 2019, 31 (4) : 726 - 732
  • [38] The projected global burden of modifiable risk factors on cardiovascular disease from 2025 to 2100
    Chong, B.
    Jayabaskaran, J.
    Kueh, M.
    Goh, R.
    Li, H.
    Foo, R.
    Chan, M.
    Chew, N.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [39] Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis
    Stavropoulos-Kalinoglou, A.
    Metsios, G. S.
    Panoulas, V. F.
    Douglas, K. M. J.
    Nevill, A. M.
    Jamurtas, A. Z.
    Kita, M.
    Koutedakis, Y.
    Kitas, G. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (02) : 242 - 245
  • [40] The association between stair climbing and modifiable cardiovascular disease risk factors: the Suita Study
    Arafa, Ahmed
    Yasui, Yuka
    Kato, Yuka
    Matsumoto, Chisa
    Kokubo, Yoshihiro
    ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE, 2024, 29
12345